Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery.

Elbadawi A, Elgendy IY, Saad M, Megaly M, Mentias A, Abuzaid AS, Shahin HI, Goswamy V, Abowali H, London B.

Ann Thorac Surg. 2018 May;105(5):1403-1410. doi: 10.1016/j.athoracsur.2017.11.027. Epub 2018 Mar 21.

PMID:
29573810
2.

Emerging technologies for the non-invasive characterization of physical-mechanical properties of tablets.

Dave VS, Shahin HI, Youngren-Ortiz SR, Chougule MB, Haware RV.

Int J Pharm. 2017 Oct 30;532(1):299-312. doi: 10.1016/j.ijpharm.2017.09.009. Epub 2017 Sep 6. Review.

PMID:
28888977
3.

Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting (From the National Inpatient Sample Database).

Elbadawi A, Ogunbayo GO, Elgendy IY, Olorunfemi O, Saad M, Ha LD, Alotaki E, Baig B, Abuzaid AS, Shahin HI, Shah A, Rao M.

Am J Cardiol. 2017 Sep 15;120(6):953-958. doi: 10.1016/j.amjcard.2017.06.025. Epub 2017 Jun 28.

PMID:
28754565
4.

Physical characterization of hematopoietic stem cells using multidirectional label-free light scatterings.

Shahin H, Gupta M, Janowska-Wieczorek A, Rozmus W, Tsui YY.

Opt Express. 2016 Dec 12;24(25):28877-28888. doi: 10.1364/OE.24.028877.

PMID:
27958553
5.

Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial.

Elbadawi A, Gasioch G, Elgendy IY, Mahmoud AN, Ha LD, Ashry HA, Shahin H, Hamza MA, Abuzaid AS, Saad M.

Cardiol Ther. 2016 Dec;5(2):203-213. Epub 2016 Nov 14.

6.

Design and In Vitro/In Vivo Evaluation of Ultra-Thin Mucoadhesive Buccal Film Containing Fluticasone Propionate.

Ammar HO, Ghorab MM, Mahmoud AA, Shahin HI.

AAPS PharmSciTech. 2017 Jan 1;18(1):93-103. doi: 10.1208/s12249-016-0496-0. Epub 2016 Feb 16.

PMID:
26883262
7.

Reply to Tzoulis et al.: Genetic and clinical heterogeneity of essential tremor.

Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2269. doi: 10.1073/pnas.1503756112. Epub 2015 Mar 30. No abstract available.

8.

Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease.

Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18285-90. doi: 10.1073/pnas.1419581111. Epub 2014 Nov 24.

9.

Zr-Y-Nb-REE mineralization associated with microgranite and basic dykes at EL Sela shear zone, South Eastern Desert, Egypt.

Shahin HA.

Springerplus. 2014 Oct 1;3:573. doi: 10.1186/2193-1801-3-573. eCollection 2014.

10.

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.

Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC; Epo Severe TBI Trial Investigators, Baldwin A, Rivera Lara L, Saucedo-Crespo H, Ahmed O, Sadasivan S, Ponce L, Cruz-Navarro J, Shahin H, Aisiku IP, Doshi P, Valadka A, Neipert L, Waguspack JM, Rubin ML, Benoit JS, Swank P.

JAMA. 2014 Jul 2;312(1):36-47. doi: 10.1001/jama.2014.6490.

11.

Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.

Ayas M, Siddiqui K, Al-Jefri A, El-Solh H, Al-Ahmari A, Khairy A, Markiz S, Shahin H, Al-Musa A, Al-Seraihy A.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1599-603. doi: 10.1016/j.bbmt.2014.06.016. Epub 2014 Jun 21.

12.

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.

Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM.

Cell. 2013 Aug 1;154(3):518-29. doi: 10.1016/j.cell.2013.06.049.

13.

Mutations in OTOGL, encoding the inner ear protein otogelin-like, cause moderate sensorineural hearing loss.

Yariz KO, Duman D, Zazo Seco C, Dallman J, Huang M, Peters TA, Sirmaci A, Lu N, Schraders M, Skromne I, Oostrik J, Diaz-Horta O, Young JI, Tokgoz-Yilmaz S, Konukseven O, Shahin H, Hetterschijt L, Kanaan M, Oonk AM, Edwards YJ, Li H, Atalay S, Blanton S, Desmidt AA, Liu XZ, Pennings RJ, Lu Z, Chen ZY, Kremer H, Tekin M.

Am J Hum Genet. 2012 Nov 2;91(5):872-82. doi: 10.1016/j.ajhg.2012.09.011.

14.

GPSM2 mutations cause the brain malformations and hearing loss in Chudley-McCullough syndrome.

Doherty D, Chudley AE, Coghlan G, Ishak GE, Innes AM, Lemire EG, Rogers RC, Mhanni AA, Phelps IG, Jones SJ, Zhan SH, Fejes AP, Shahin H, Kanaan M, Akay H, Tekin M; FORGE Canada Consortium, Triggs-Raine B, Zelinski T.

Am J Hum Genet. 2012 Jun 8;90(6):1088-93. doi: 10.1016/j.ajhg.2012.04.008. Epub 2012 May 10. Erratum in: Am J Hum Genet. 2012 Jul 13;91(1):209.

15.

Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families.

Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A, Parzefall T, Lev D, Shalev S, Frydman M, Davidov B, Shohat M, Rahile M, Lieberman S, Levy-Lahad E, Lee MK, Shomron N, King MC, Walsh T, Kanaan M, Avraham KB.

Genome Biol. 2011 Sep 14;12(9):R89. doi: 10.1186/gb-2011-12-9-r89.

16.

A mouse model for human hearing loss DFNB30 due to loss of function of myosin IIIA.

Walsh VL, Raviv D, Dror AA, Shahin H, Walsh T, Kanaan MN, Avraham KB, King MC.

Mamm Genome. 2011 Apr;22(3-4):170-7. doi: 10.1007/s00335-010-9310-6. Epub 2010 Dec 17.

PMID:
21165622
17.

Influence of alcohol on early Glasgow Coma Scale in head-injured patients.

Shahin H, Gopinath SP, Robertson CS.

J Trauma. 2010 Nov;69(5):1176-81; discussion 1181. doi: 10.1097/TA.0b013e3181edbd47.

18.

Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51.

Walsh T, Pierce SB, Lenz DR, Brownstein Z, Dagan-Rosenfeld O, Shahin H, Roeb W, McCarthy S, Nord AS, Gordon CR, Ben-Neriah Z, Sebat J, Kanaan M, Lee MK, Frydman M, King MC, Avraham KB.

Am J Hum Genet. 2010 Jul 9;87(1):101-9. doi: 10.1016/j.ajhg.2010.05.011. Epub 2010 Jun 17.

19.

Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82.

Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W, Abu Rayyan A, Loulus S, Avraham KB, King MC, Kanaan M.

Am J Hum Genet. 2010 Jul 9;87(1):90-4. doi: 10.1016/j.ajhg.2010.05.010. Epub 2010 Jun 17.

20.

Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.

Shahin H, Rahil M, Abu Rayan A, Avraham KB, King MC, Kanaan M, Walsh T.

J Med Genet. 2010 Sep;47(9):643-5. doi: 10.1136/jmg.2009.075697. Epub 2010 May 14.

PMID:
20472657

Supplemental Content

Loading ...
Support Center